Further, cells where SOS2 had been deleted showed an approximately 1-log enhancement in BAY-293 efficacy and enhanced overall growth inhibition compared to NT controls, indicating that SOS1 and SOS2 have some overlapping functions in supporting survival of spheroid cultured EGFR-mutated NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.